Jade Biosciences, Inc. Unrealized Gain (Loss) on Investments
Jade Biosciences, Inc. (JBIO) reported Unrealized Gain (Loss) on Investments of -$245.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-10
- Jade Biosciences, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was -$245.00K.
- Jade Biosciences, Inc. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $35.00K.
- Jade Biosciences, Inc. unrealized gain (loss) on investments for the quarter ending 2024-09-30 was $0.00.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 9 month |
|---|---|---|
| 2026-06-30 | -$245.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-14 | $35.00K 10-Q · filed 2025-11-14 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |